APPLICATIONS PUBLISHED 18 OCTOBER 2006
 Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
Durect    1711160*
 Methods for preventing and treating SARS using low Ph respiratory tract compsns
Procter & Gamble    1711161*
 Method for the diffusion of molecules which are insoluble in an aqueous medium and compsn using said method
Perovitch, Phillippe, Maury, Marc    1711162*
 Dispersions prepared by use of self-stabilised agents
Baxter International    1711163*
 Method of treating acute rhinosinusitis
Schering    1711164*
 Membrane scaffold proteins
The Board of Trustees of the University of Illinois    1711165*
 Stable amorphous forms of montelukast sodium
Chemagis    1711166*
 Multiparticulate O-desmethylvenlafaxine salts and uses thereof
Wyeth    1711167*
 Oral pharmaceutical compsns of candesartan cilexetil
Ranbaxy Laboratories    1711168*
 Extended release coated microtablets of venlafaxine hydrochloride
Alembic     1711169*
 Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
Lavipharm Laboratories    1711170*
 Vitamin E for facilitating the synchronisation of circadian rhythm
DSM IP Assets    1711171*
 Compsns and methods for combined therapy of disease
The Trustees of the University of Pennsylvania    1711173*
 Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or ester thereof
Igennus    1711173*
 Adjuvant compsns
MNL Pharma    1711174*
 Diurea derivatives
Active Biotech    1711175*
 Immunomodulatory alkaloids
MNL Pharma    1711176*
 1H-thieno 2,3-c pyrazole derivatives useful as kinase inhibitors
Pfizer Italia    1711177*
 Compsns substantially free of galactomannan containing piperacillin and tazobactam
Wyeth    1711178*
 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (S)-pantoprazole
Altana Pharma    1711179*
 Thiazolyimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
Merck Patent    1711180*
 Quinoline derivatives and use thereof as mycobacterial inhibitors
Janssen Pharmaceutica    1711181*
 Oral cyclodextrin complexes of anti-tuberculosis drugs
Sapte, Vinay Ramakant    1711182*
 Muscarinic acetylcholine receptor antagonists
Glaxo Grouo    1711183*
 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
Janssen Pharmaceutica    1711184*
 Combination of CDK inhibitor and CS-682 or a metabolite thereof
Cyclacel    1711185*
 Slow release steroid compsn
RetMed Pty    1711186*
 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
Advisys    1711187*
 Anticancer therapies
Threshold Pharmaceuticals    1711188*
 6,11,3C-bicyclic 8A-azalide derivatives
Merck    1711189*